Second-Line Hormonal Treatments for Advanced Prostate Cancer - Urology

Share to:

Please ask your questions regarding second-line hormones?


Dear Director Hsu,
I admire your dedication in responding to inquiries from netizens amidst your busy schedule at Taiwan e-Hospital.
My father-in-law is a terminal prostate cancer patient who has been undergoing hormone injection therapy for over two years.
Recently, his PSA levels have shown an upward trend for the past two months, and his attending physician has indicated that the hormone therapy may have become ineffective.
We are considering switching to second-line hormone therapy soon.

The first-line hormone therapy we used was very effective, allowing for 2-3 years of pain-free living without bone issues.
From my research online, I found that hormone therapy typically loses effectiveness after about two years.
Now that we are looking into second-line hormone medications, we have encountered vague and ambiguous information.
I would like to ask you about the following regarding second-line hormone therapy:
1.
How many types of second-line hormone medications are available?
2.
Are all of them effective?
3.
How long does the efficacy of second-line hormone medications generally last?
4.
Is it possible for them to be as effective as the first-line treatments for 2-3 years?
5.
If second-line hormone therapy is ineffective, what are the potential outcomes for chemotherapy afterward?
I apologize for the numerous questions.
After reviewing a lot of online medical information, we have a general understanding of the future treatment options, but we would like to gain a clearer perspective on the path ahead.
Given my father-in-law's advanced age, we need to consider all aspects carefully.
Please feel free to respond candidly, and I appreciate your assistance in advance.
Thank you very much.

Mo Li Hua, 50~59 year old female. Ask Date: 2011/05/22

Dr. Xu Weikai reply Urology


Jasmine: Hello, I personally do not have much experience with second-line hormone therapy, and I cannot provide you with extensive information.
It may be more appropriate to consult directly with your attending physician for detailed advice.
Additionally, if the treatment is ineffective, you might consider orchiectomy, which can reduce the concentration of male hormones in the blood by 95%, making subsequent treatments simpler.
If there are any unclear points, feel free to ask again, and we can discuss and research further.
This response is from Dr.
Hsu Wei-Kai, Director of Urology, Taitung Hospital, Department of Health, Executive Yuan, who cares about your situation.

Reply Date: 2011/05/22

More Info


Understanding second-line hormonal treatments for advanced prostate cancer is crucial, especially for patients who have experienced a rise in PSA levels after initial hormonal therapy. In your case, your father has been on hormone injections for over two years, and the recent increase in PSA indicates that the first-line hormonal therapy may no longer be effective. This situation is not uncommon, as prostate cancer can develop resistance to hormonal treatments over time.


Types of Second-Line Hormonal Therapies
Second-line hormonal therapies typically include several options, each with varying mechanisms of action and effectiveness. The most commonly used second-line hormonal agents include:
1. Abiraterone Acetate (Zytiga): This drug works by inhibiting the production of androgens (male hormones) not only in the testes but also in the adrenal glands and within the tumor itself. It is often used in combination with prednisone to manage side effects.

2. Enzalutamide (Xtandi): This medication is an androgen receptor inhibitor that blocks the action of androgens at the receptor level, preventing cancer cells from utilizing testosterone for growth.

3. Darolutamide (Nubeqa): Similar to enzalutamide, darolutamide is another androgen receptor inhibitor but is noted for having a favorable side effect profile.

4. Docetaxel (Taxotere): While primarily a chemotherapy agent, docetaxel can be used in patients with hormone-resistant prostate cancer, especially if there are symptoms or significant disease progression.

5. Cabazitaxel (Jevtana): This is another chemotherapy option for patients who have progressed on docetaxel.


Effectiveness and Duration of Treatment
The effectiveness of second-line hormonal therapies can vary significantly among patients. Some patients may experience a substantial reduction in PSA levels and an improvement in symptoms, while others may not respond as well. Generally, the duration of effectiveness for second-line hormonal treatments can range from several months to a few years, depending on individual factors such as the biology of the cancer, previous treatments, and overall health.

While some patients may achieve a response similar to that seen with first-line therapies (2-3 years), others may find that the duration of benefit is shorter. It is essential to have realistic expectations and to discuss these with your father's healthcare team.


Next Steps if Second-Line Hormonal Therapy Fails
If second-line hormonal treatments are ineffective, there are several options to consider:
1. Chemotherapy: As mentioned earlier, docetaxel and cabazitaxel are viable options. Chemotherapy can be effective in controlling symptoms and slowing disease progression.

2. Radium-223 (Xofigo): This is a targeted radiopharmaceutical treatment specifically for patients with bone metastases and can help alleviate pain and improve quality of life.

3. Clinical Trials: Participating in clinical trials may provide access to new and emerging therapies that are not yet widely available.

4. Palliative Care: Focusing on symptom management and quality of life is crucial, especially in advanced stages of cancer. Palliative care can help manage pain and other symptoms effectively.


Conclusion
Navigating the treatment landscape for advanced prostate cancer can be complex, especially when considering second-line hormonal therapies. It is essential to maintain open communication with your father's healthcare team to tailor the treatment plan to his specific needs and preferences. Each patient's journey is unique, and understanding the available options can empower you and your family to make informed decisions about his care. Thank you for your thoughtful questions, and I wish you and your family the best in this challenging time.

Similar Q&A

Combining Radium-223 with Second-Line Hormonal Therapy: Key Considerations

Hello, I have stage IV prostate cancer with bone metastasis and have developed bone pain. My PSA level has exceeded 100, and I am currently awaiting Radium-223 treatment. I would like to inquire about the use of enzalutamide to suppress the rate of PSA increase. If I continue to ...


Dr. Jian Weihong reply Urology
Hello: Based on my understanding, Radium-223 (such as Xofigo) is to be used under specific conditions and cannot be combined with enzalutamide. It is indicated for the treatment of castration-resistant prostate cancer (CRPC) patients who have symptomatic bone metastases and no vi...

[Read More] Combining Radium-223 with Second-Line Hormonal Therapy: Key Considerations


Advanced Prostate Cancer: Treatment Options and Life Expectancy

In the case of stage IV prostate cancer that has metastasized to the pelvis, treatment options typically include hormone therapy, chemotherapy, radiation therapy, and possibly targeted therapy or immunotherapy. Each treatment may lead to various side effects, such as fatigue, nau...


Dr. Du Shixi reply Urology
Hello: 1) Treatment should be tailored to the patient's condition. In advanced stages, both radiation therapy and hormone therapy are utilized, depending on the facilities available at each hospital and the patient's physical condition, with varying effectiveness. 2) Ac...

[Read More] Advanced Prostate Cancer: Treatment Options and Life Expectancy


Understanding Prostate Cancer: Managing Urinary Issues and Hormone Therapy Options

Hello Doctor, my father had a PSA level of 32.5 and a prostate volume of 45 in September. He underwent a laser enucleation procedure, and the biopsy results confirmed prostate cancer. The doctor arranged for a bone scan and MRI, which showed no bone metastasis or involvement of o...


Dr. Li Minghui reply Urology
Hello: 1) Postoperative urinary incontinence generally improves gradually over several months. If the amount of leakage decreases, it will continue to improve. Medication can also help, but the extent of recovery may vary. 2) Hormonal therapy is a common treatment option that sup...

[Read More] Understanding Prostate Cancer: Managing Urinary Issues and Hormone Therapy Options


Understanding Stage 2 Prostate Cancer: Treatment Options for Seniors

Prostate cancer, diagnosed as stage II after hospital examination, and the patient is currently 80 years old. I would like to know which treatment option is better among surgery, chemotherapy, and medication, or if there are other effective treatment methods. Thank you.


Dr. Liu Jiaju reply Urology
Prostate cancer generally progresses more slowly compared to other cancers. Given that patients are often older, if aggressive treatment is considered, radiation therapy is recommended, as it has good efficacy and tolerability for patients. If the patient's overall health is...

[Read More] Understanding Stage 2 Prostate Cancer: Treatment Options for Seniors


Related FAQ

Prostate Cancer

(Urology)

Testosterone

(Urology)

Steroids

(Urology)

Sildenafil

(Urology)

Post-Prostate Surgery

(Urology)

Hematospermia

(Urology)

Prostate-Specific Antigen

(Urology)

Other

(Urology)

Prostatic Fluid

(Urology)

Adrenal Tumor

(Urology)